Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-11

Clinical Trial Update: Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing hypo-fractionation versus conventional fractionation in reconstructed breast cancer mastectomy patients; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Breast Cancer, Radiotherapy; Complications | Phase 3 | Status: NOT_YET_RECRUITING